Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 14/11/19971 min de lectura
Iatric Corp.; Revocation of Product License for Coccidioidin, USP (BioCox)
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the revocation of the biological product license issued to Iatric Corp., Tempe, AZ, for the manufacture of Coccidioidin, USP (BioCox). In a letter to FDA dated May 13, 1997, Iatric Corp. voluntarily requested revocation of its product license for Coccidioidin, USP (BioCox). In a letter dated June 25, 1997, FDA informed the firm that its product license for Coccidioidin, USP (BioCox) was revoked.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →